17
,17'-bis3-[bis(2-chloroethyl)carbamoyloxy]estra1,3,5(10)-trienyl pyrophosphate
| Catalogue Number | Pack Size | Price | Batch Number | Expiry Date |
|
49 | 25mg | 97 | 3013 | 3 months from despatch |
|
| Availability | Quantitative | Storage Conditions | Controlled Drug |
| Yes | No | | No |
|
| Declared Content |
See BPCRSL 94
|
|
| Leaflets | Chromatograms |
  | |
|
| Health And Safety (More Information) |
BRITISH PHARMACOPOEIA COMMISSION
BRITISH PHARMACOPOEIA CHEMICAL REFERENCE SUBSTANCES (BPCRS)
HEALTH AND SAFETY INFORMATION
NAME:
17{b},17'{b}-bis(3-[bis-(2-chloroethyl)carbamoyloxy]estra-1,3,5,(10)-trienyl)pyrophosphate
HAZARDOUS NATURE:
Harmful, steroidal hormone derivative, maybe carcinogenic
RISK TO HEALTH:
By skin contact
PRECAUTIONS:
Avoid all skin contact
FIRST AID:
Wash affected area thoroughly with water, do not use organic solvents
March 1990 |
|
Monograph: estramustine sodium phosphate
